Saturn V Capital Management’s MoonLake Immunotherapeutics MLTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$13.7M	Sell	290,784 -53,065	-15%	-$2.5M	5.56%	10
2025 Q1	$13.4M	Sell	343,849 -2,262	-0.7%	-$88.4K	6.78%	6
2024 Q4	$18.7M	Buy	346,111 +47,137	+16%	+$2.55M	7.34%	3
2024 Q3	$15.1M	Buy	+298,974	New	+$15.1M	5.39%	9